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Abstract: 
Objective. Since 1930, dietary modification has been proposed as adjunct 
treatment in Ménière's disease (MD) with different and controversial 
results. The Authors reported the case of a 42-year-old female suffering 
from definite MD and intermittent seasonal allergic rhino-conjunctivitis 
because it highlights the importance of evaluating the different 
combinations of defined causative elements in an atopic patient with MD. 
Methods. An immunological and audiological evaluation has been 
performed, including pure-tone, speech and immitance audiometry, 
glycerol dehydration test, bithermal caloric testing, video-head impulse 
test, cervical vestibular evoked myogenic potentials, static posturography 
and Dizziness Handicap Inventory questionnaire. Results. Milk-free diet 
was crucial to the relief from MD symptoms and the cow’s milk challenge 
test was able to evoke them but vestibukar symptoms persists. 
Conclusions. The effect of dietary modification was evident only after 
specific immunotherapies against other allergens. This highlights the 
importance of evaluating different combinations of defined causative 
elements also in the allergic treatment of MD. 
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2 
Abstract 
Objective. Since 1930, dietary modification has been proposed as adjunct treatment in 
Ménière's disease (MD) with different and controversial results. The Authors reported the 
case of a 42-year-old female suffering from definite MD and intermittent seasonal allergic 
rhino-conjunctivitis because it highlights the importance of evaluating the different 
combinations of defined causative elements in an atopic patient with MD. Methods. An 
immunological and audiological evaluation has been performed, including pure-tone, speech 
and immitance audiometry, glycerol dehydration test, bithermal caloric testing, video-head 
impulse test, cervical vestibular evoked myogenic potentials, static posturography and 
Dizziness Handicap Inventory questionnaire. Results. Milk-free diet was crucial to the relief 
from MD symptoms and the cow’s milk challenge test was able to evoke them but vestibukar 
symptoms persists. Conclusions. The effect of dietary modification was evident only after 
specific immunotherapies against other allergens. This highlights the importance of 
evaluating different combinations of defined causative elements also in the allergic treatment 
of MD. 
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3 
Introduction 
 
 Since 1930, low salt diet has been proposed to treat Ménière’s disease (MD) patients 
[1] and inhalant and food allergies have been linked with MD symptoms. [2] In 1972, Bryan 
& Bryan first reported a benefit in MD patients following an elimination diet for documented 
food allergies. [3] In 2000, Derebery claimed that the prevalence of allergy in patients with 
MD is almost three times that of the general population. [4] The immunological facets of 
allergy and their relationship with MD has been explained in different ways. [5] Among the 
most common food allergens, the role of wheat and milk in MD has been hypothesized. [5, 6, 
7] Animal studies have shown evidence of immunologic activity within the inner ear in MD. 
[8] 
 In a recent review by Weinreich and Agrawal, [9] a possible association between 
allergy and MD has been observed in a number of cross-sectional and observational studies, 
suggesting the need for inclusion of allergy control in the treatment plan for bilateral MD, or 
in case of development of symptoms within a short time after exposure to food or inhaled 
allergens. However, in multifactorial conditions, such as in MD, and in immune mediated 
diseases, the effect of causative therapies on symptoms might not be immediately detected. 
[10] 
 
 We add to this unresolved issue a personal observation on a MD patient in whom only 
a combination of a specific diet and immunotherapies was able to relieve the patient from her 
symptoms. 
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4 
Case history 
 
 We describe the case of a 42-year-old female affected, since 2009, by “definite” MD 
in her left ear, according to the criteria of the American Academy of Otolaryngology-Head 
and Neck Surgery Committee on Hearing and Equilibrium (AAOHNS-CHE). [10] 
She started complaining of tinnitus in 2001 (Tinnitus Handicap Inventory [THI]: 42/100); 
vertigo and aural fullness began in 2008 with recurrent episodes (more than 4 episode/month) 
of audiometrically documented sensorineural hearing loss of at least 60 dB HL in the left ear; 
word repetition score was 100% at 80 dB HL during the acute stage. (Figure 1). During 
vertigo spells, the patient also experienced hearing loss, tinnitus, and aural pressure; all 
symptoms would disappear after a few hours of bed rest. Glycerol dehydration test showed an 
improvement of 20 dB HL at the pure-tone threshold at 250-500 Hz in the acute phase. A left 
peripheral vestibular weakness was detected by bithermal caloric testing according to the 
Hallpike technique and Jongkee’s formulae); the head impulse vestibulo-ocular reflex gain 
was decreased on the left side, by video-head impulse test (vHIT). Since the initial diagnosis 
of MD, she had been treated with a low-sodium diet, diuretics, and steroids, but none of the 
symptoms had improved. In the critical phase, the cervical vestibular evoked myogenic 
potentials (cVEMP) revealed a bilateral absence of p13-n23 complex; transiently evoked 
otoacoustic emission (TEOAE) were bilaterally absent (Figure 2) and the functional 
stabilometric parameters (SVEP system 6.0, Amplaid, Politecnica Modena, Italy) were 
persistently abnormal during critical and intercritical phases. From 2008 to 2013, more than 4 
episode/month occurred repeatedly, while the symptoms-free intervals lasted no more than 6 
weeks. The vertigo spells were more frequent in February, March, May, June and November. 
During those months, the presence of aeroallergens (count per cubic meter) that were 
regularly monitored throughout the year by checking the bulletin obtained from the local 
Pollen Count Station [11], reached their concentration peaks. 
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5 
Disability was evaluated by the Dizziness Handicap Inventory (DHI: 56/100, physical 14, 
emotional 18 and functional 24).  
The patient had suffered from intermittent and seasonal allergic rhino-conjunctivitis since 
1985. In 2012, skin tests were carried out in accordance with the recommendations of the 
European Academy of Allergology and Clinical Immunology [12]: prick tests were positive 
to house dust mite, grass and birch pollen, and cow milk proteins, while they were negative to 
the other most common inhalant and fresh food allergens and to gliadin, even after 24 hours.  
Specific IgE to Dermatophagoides mix, grass pollen, betulaceae and milk were in class 3 - 4 
(RAST-CAP System EIA method, Pharmacia, Uppsala, Sweden.). The common 
autoantibodies profile was negative. A possible role of allergy in the symptoms of MD was 
suspected and, in October 2012, the patient initially tried a deprivation diet, eliminating foods 
that contain cow milk and its derivatives. The patient was allowed to consume only soy and 
rice milk, while other milk products, such as sheep or goat milk/cheese were avoided, but 
symptoms persisted for the following six months. No other pharmacological treatment was 
administered during and after the dietary period. In March 2013, the patient began two 
concurrent subcutaneous immunotherapies (SARM allergeni, Guidonia-Rome, Italy) one for 
mites (40% Dermatophagoides, 30% Gliciphagidae and 30% Acaridae) and another one for 
grass pollen (80% mix: Dactylis, Festuca, Lolium, Phleum, Poa, Agrostis, Antoxanthum and 
20% Cynodon D).  
The remission of the majority of MD symptoms (excluding tinnitus) was achieved during the 
first three months after treatment. Pure tone threshold audiometry showed a steady gain of air-
conducted hearing threshold up to 30 dB HL at 500-1000-2000 Hz; word recognition score 
reached 100% at 40 dB HL; (Figure 1) similarly, over the same period the allergic symptoms 
progressively decreased in a significant manner. The stabilometric parameters returned to 
normal values and TEOAE were elicited in more than two occasions. (Figure 2) On the other 
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6 
hand, a persistence of the left peripheral vestibular weakness was detected upon bithermal 
caloric testing and vHIT. while, during the remission phase, c-VEMPS were not retested.  
The benefits persisted for one year during the exclusion diet, until the patient agreed to 
undergo an open challenge; in February 2014, cow milk and its derivatives were reintroduced 
in her diet; this challenge procedure is considered the reference gold standard for the 
diagnosis of cow’s milk proteins allergy according to the diagnostic recommendations 
guidelines. [12] This provocation test caused an acute episode with an audiometrically 
documented sensorineural hearing loss of 60 dB HL in the left ear, disappearing of TEOAE 
and the reactivation of MD symptoms, occurring 6 hours after the ingestion. The symptoms 
subsided after two days when milk was once again removed from the diet. The benefits of 
immunotherapy on MD symptoms still persist 2 years and a half after the milk challenge test. 
Up to date, the patient is still free from vertigo and hearing fluctuations; she is only 
complaining of a mild tinnitus (THI 12/100). DHI has greatly improved to 8/100 (physical 0, 
emotional 2 and functional 6). 
The comparison between the frequency of MD attacks during the 6 months prior to the 
immunomodulation treatment and the 18 to 24 months period after treatment, according to the 
AAO-CHE guidelines, showed a “complete” control of definite spells (class A). (Table 1) 
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7 
Discussion 
  
 MD, likewise atopy, is a multifactorial condition. [13] Possible correlations between 
multifactorial diseases are very difficult to establish, particularly when the causative effect is 
not immediate; large cohorts of homogeneous patients need to be recruited for conducting 
randomized clinical studies and this explains the still incompletely proven relationship 
between the two conditions; in this respect clinical case reports acquire relevance. In a 
previous study from our group, [7] sensitivity to gluten was found to be associated with MD 
and the incidence of atopy was confirmed to be high in MD subjects. In 2000, Derebery first 
reported data from a mail-posted survey showing overall decrease of MD and allergy 
symptoms secondary to anti-allergic treatment. [5] The same author concluded that it is 
logical to assume that down-regulating the production and release of pro-inflammatory and 
vasoactive mediators that promote fluid extravasation and/or retention could help lessen the 
symptoms of MD. The ingestion of causative allergens also might induce an altered 
gastroenteric permeability in patients with hypersensitivity; [14] it is not known if this 
condition can induce a variation in the electrolytic balance.  
 The patient’s increase of vertigo spells in February, March, May, June and November 
paralleled the raised inhalant allergen concentrations. Based on the local Pollen Count by the 
European approved monitoring station [11], in the patient’s environment the Betulaceae 
reached their peaks in February and March and grass pollen in May and June. Furthermore, in 
November, an increase of dust mites is commonly reported, due to the house heating onset 
and the subsequent rise of room temperatures. [15, 16] 
 
 Antigens avoidance and specific immunotherapy (SIT) are the only accepted 
treatments that can favourably change the natural history of allergic disease, because they are 
reconditioning the immune system to a specific level of tolerance towards the allergens (a.k.a. 
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8 
immunomodulation). [17] However, even if an international consensus has been reached in 
2015 [17] about immunomodulation of allergic patients with SIT, its role in MD patients is 
still unclear. [9] In our patient, the target of SIT was to induce the specific hypo-sensitization 
to aeroallergens; besides that, it helped us finding the concomitant hyper-sensitization to 
cow’s milk. The causative components of milk allergy, according to the World Allergy 
Organization (WAO) Special Committee on Food Allergy guidelines, are supposed to be the 
cow milk proteins [18]  
 On the other hand, the patient did not show any allergic reaction to the oral intake of 
foods which are cross-reacting with aeroallegens (apple, pear, halzelnut, carrots, selery and 
fennel with Betulaceae, tomato with grass pollen and shrimps with mites), thus showing a 
different organ target tropism. [19]  
 SIT has a profound immune-regulatory effect that may also explain why it can modify 
the course of allergic disease with a long-lasting effect even after discontinuation of 
treatment. However, SIT is a highly allergen-specific form of treatment, targeting only the 
allergens included in the vaccine; for this reason, other cross-reactive or non-immunologically 
related allergens responsible of immune inflammation remain untreated. [20] This combined 
effect of food and inhalant allergies is particularly noteworthy: immunomodulation induced 
by the elimination diet was not sufficient to treat our patient; only the more consistent 
immunomodulation prompted by the combined SIT was able to relieve her MD symptoms. 
  
 Similarly to the other immune-mediated disorders, allergy is likely to produce a bilateral 
involvement of the ear.  In the literature, a bilateral simultaneous onset of MD has been 
observed in 11% of the cases; however, the rate of delayed progression from unilateral to 
bilateral involvement is relevant; it requires long-term follow-up for identification (on 
average: 7.6 ± 7.0 years) and might be conditioned by pharmacological therapies [21]. Even if 
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9 
the majority of MD have a unilateral onset, some of the audio-vestibular tests may already 
suggest the involvement of the contralateral ear. Recent studies using 3-dimensional fluid-
attenuated inversion recovery magnetic resonance imaging showed endolymphatic hydrops in 
the asymptomatic contralateral ear in long-standing MD patients, in support of this 
hypothesis. [22] 
 In order to demonstrate the beneficial effects on MD symptoms, in some cases it might 
be useful to define and to induce immune tolerance by SIT and avoiding the contact of all 
identified antigens at the same time, instead of singularly. 
 In conclusion, we believe that the proper assessment of an allergic condition should be 
included in the diagnostic workup of MD patients, at least in selected cases based on clinical 
history, especially those with bilateral ear disease. This would avoid generic deprivation diets 
[23] and could single out those who might benefit from a tailored immune treatment, in 
association or not with the traditional pharmacological therapies. 
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13 
Table 1. Standard data table of AAOHNS-CHE raw data 
 Stage FV HT WRS FL 
Baseline  3 4 67.5 100 5 
2 years- follow-up 2 0 30.0 100 1 
 
FV: Frequency of Vertigo, definitive episodes per month for the previous 6 months;  
HT: Hearing Thresholds, pure-tone average in decibels;  
WRS: Word Recognition Score (speech discrimination) in percent;  
FL: Functional Level (1-6). 
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14 
Figure 1. Pure tone threshold and speech audiometry before (a) and after treatment at 2 years and a 
half of follow-up (b) 
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Figure 2. TEOAE evaluation before (a) and after treatment (b) 
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